Comment on original article, Cheng et al.’s “Obstructive Sleep Apnea in Relation to Beat-to-Beat, Reading-to-Reading, and Day-to-Day Blood Pressure Variability” [1].
Obstructive sleep apnea (OSA) is associated with hypertension and cardiovascular disease [2, 3]. In 786 hospitalized patients with hypertension, Cheng et al. performed 10-min awake beat-to-beat blood pressure (BP) monitoring (n = 705), 24-h ambulatory BP monitoring (ABPM) (n = 779), 7-day home BP monitoring (n = 445) and the full overnight polysomnography. Variability independent of the mean (VIM), average real variability (ARV), and maximum–minimum difference (MMD) were used as indices of BP variability. In univariate analysis, VIM and MMD in awake beat-to-beat systolic BP, and sleep systolic and diastolic ARV and MMD increased from patients without obstructive sleep apnea syndrome (OSAS), to patients with mild, moderate and severe OSAS. After adjustment for confounders, this increasing trend for VIM and MMD in awake beat-to-beat systolic BP remained statistically significant. This study reported clinically significant results. However, it has several limitations.
The first limitation is that the authors measured only awake beat-to-beat BP during daytime and not sleep beat-to-beat BP during nighttime. If sleep beat-to-beat BP had been available, the BP variability between awake and sleep beat-to-beat BP could be compared, which may become additional important findings. For example, it is clinically important whether 10-min awake beat-to-beat BP variability can predict severity of sleep beat-to-beat BP variability.
OSA induces intermittent hypoxia, recurring microarousals, sleep fragmentation, increased sympathetic nerve activity, BP elevation, and increased BP variability. In patients with OSAS, hypoxemia induced by sleep apnea episode is followed by a rapid rise in BP (sleep BP surge). Kuwabara and Kario et al. succeeded in detecting sleep BP surge in patients with OSAS using an original noninvasive device that measures brachial BP based on oscillometric method triggered by hypoxemia due to apnea episode [4]. Using the same device, Sasaki et al. revealed that peak systolic BP triggered by hypoxemia was significantly higher during rapid eye movement (REM) sleep compared with those in non-REM stage 1 and stage 2 sleep [5]. Moreover, the same study indicated that lowest oxygen saturation percentage during each sleep apnea episode was associated with maximum hypoxia-triggered systolic BP and maximum systolic BP surge. Sleep BP surges, which occur repeatedly during sleep, elevate sleep BP and increase sleep BP variability. Sympathetic nerve activation induced by hypoxia is one of the key pathophysiological mechanisms of sleep BP surge [6]. Besides, sympathetic nervous activation occurs not only during nighttime but also extends into the daytime [7]. This causes sustained daytime hypertension in patients with OSAS. Fig. 1.
Even today, the gold standard of BP measurement for office BP, ABPM, and home BP is the brachial BP measurement. In recent years, finger BP monitoring devices, including Finometer device used in the study by Cheng et al., have allowed to measure beat-to-beat BP noninvasively. Although BP based on finger BP monitoring devise is less accurate than BP based on brachial BP measurement, only finger BP monitoring device allows measuring whole of dynamically fluctuating BP in patients with OSAS. This is a major advantage of beat-to-beat BP monitoring. Using data from 330 patients with sleep disordered breathing (mean 3% oxygen desaturation index, 21.0 ± 15.0/h), Hoshide et al. measured nighttime beat-to-beat BP based on BP determined by pulse transit time (PTT) obtained at the site of finger. The authors reported that the average systolic beat-to-beat BP, maximum systolic and diastolic beat-to-beat BP, standard deviation (SD) of systolic and diastolic beat-to-beat BP, and coefficient variation (CV) of systolic and diastolic beat-to-beat BP were significantly higher than the respective values of intermittent BP determined by PTT at fixed time intervals [8].
The second limitation of the study by Cheng et al. is that 80% of the study participants were taking antihypertensive medication. Antihypertensive medications decrease elevated BP induced by OSA [9, 10]. Therefore, it is possible that BP and BP variability differed between patients taking antihypertensive medications and those not taking antihypertensive medications, which may have influenced the results of this study.
A notable result reported by Cheng et al. is that VIM and MMD in awake beat-to-beat systolic BP were increased in patients with severe OSAS, especially in younger, obese patients. Yoshida et al. previously reported a case of a 36-year-old young male having severe OSAS and obesity who experienced three nocturnal-onset stroke events [11]. This patient had large sleep BP surges, and his maximum sleep systolic BP measured by hypoxia-triggered sleep BP monitoring device had reached 209 mm Hg. The authors concluded that sleep BP surge in patients with OSAS could be a strong trigger of cardiovascular events. As Cheng et al. stated in the discussion, increased awake beat-to-beat BP variability may help to stratify risk in patients with OSAS. Regarding this, long-term prospective studies are needed.
References
Cheng YB, Guo QH, Xia JH, Zhang J, Xu TY, Li Y, et al. Obstructive sleep apnea in relation to beat-to-beat, reading-to-reading, and day-to-day blood pressure variability. Hypertension Res. 2024. https://doi.org/10.1038/s41440-024-01628-4.
Yeghiazarians Y, Jneid H, Tietjens JR, Redline S, Brown DL, El-Sherif N, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;144:e56–e67.
Cabrini ML, Macedo TA, Castro E, de Barros S, Azam I, Pio-Abreu A, et al. Obstructive sleep apnea and hypertension-mediated organ damage in nonresistant and resistant hypertension. Hypertension Res 2023;46:2033–43.
Kuwabara M, Hamasaki H, Tomitani N, Shiga T, Kario K. Novel triggered nocturnal blood pressure monitoring for sleep apnea syndrome: distribution and reproducibility of hypoxia-triggered nocturnal blood pressure measurements. J Clin Hypertens. 2017;19:30–7.
Sasaki N, Nagai M, Mizuno H, Kuwabara M, Hoshide S, Kario K. Associations between characteristics of obstructive sleep apnea and nocturnal blood pressure surge. Hypertension. 2018;72:1133–40.
Kario K, Hettrick DA, Prejbisz A, Januszewicz A. Obstructive sleep apnea-induced neurogenic nocturnal hypertension: a potential role of renal denervation? Hypertension. 2021;77:1047–60.
Dissanayake HU, Bin YS, Ucak S, de Chazal P, Sutherland K, Cistulli PA. Association between autonomic function and obstructive sleep apnea: a systematic review. Sleep Med Rev. 2021;57:101470.
Hoshide S, Yoshihisa A, Tsuchida F, Mizuno H, Teragawa H, Kasai T, et al. Pulse transit time-estimated blood pressure: a comparison of beat-to-beat and intermittent measurement. Hypertension Res. 2022;45:1001–7.
Pepin JL, Tamisier R, Barone-Rochette G, Launois SH, Levy P, Baguet JP. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010;182:954–60.
Kario K, Kuwabara M, Hoshide S, Nagai M, Shimpo M. Effects of nighttime single-dose administration of vasodilating vs sympatholytic antihypertensive agents on sleep blood pressure in hypertensive patients with sleep apnea syndrome. J Clin Hypertens. 2014;16:459–66.
Yoshida T, Kuwabara M, Hoshide S, Kario K. Recurrence of stroke caused by nocturnal hypoxia-induced blood pressure surge in a young adult male with severe obstructive sleep apnea syndrome. J Am Soc Hypertension. 2016;10:201–4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mizuno, H. Hypertension and blood pressure variability in patients with obstructive sleep apnea. Hypertens Res (2024). https://doi.org/10.1038/s41440-024-01714-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41440-024-01714-7